Prof Nicole Déglon Dr Liliane Tenenbaum
Assoc. Professor Privat-Docent, Group Leader
Head of laboratory, Head of CRN
The laboratory’s activities are focusing on the development and validation of innovative neurotherapies and neuromodulation strategies. The three principal investigators are focusing on:
> Modulation of neuroinflammation and drug-inducible gene therapy of Parkinson’s disease.
> Underlying molecular and environmenental mechanisms in Huntington’s disease (HD).
> Pre-clinical development of molecular therapies for Huntington’s disease (HTT gene editing).
Additional information: UNIL web site